相关实验视频

Updated: Sep 11, 2025

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

唐氏综合征和没有痴呆症的胆诺托普基底前脑连接组功能障碍

Marta Moreno-Rodriguez¹, Sylvia E Perez¹, Muhammad Nadeem¹

¹Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ 85013, USA.

|August 18, 2025

概括

神经生长因子 (NGF) 信号在唐氏综合征 (DS) 中发生变化. 痴呆症患者的p75^NTR神经元减少,p75^NTR/proNGF增加,这表明痴呆症在进展中的作用.

科学领域:

神经科学是一个神经科学.
神经退行性疾病神经退行性疾病
遗传学是一个遗传学.

背景情况:

胆基底前脑 (CTBF) 神经元依赖神经生长因子 (NGF) 信号传递来生存.
唐氏综合征 (DS) 涉及NGF系统功能障碍,但痴呆症的发展在个体之间有所不同.
了解痴呆症与非痴呆症DS个体的NGF通路差异至关重要.

研究的目的:

研究患有DS (DSD+) 的痴呆个体和患有DS (DSD-) 的非痴呆个体之间的NGF信号通路的差异.
将这些途径与年龄匹配对照 (AMC) 进行比较.

主要方法:

在Meynert的基底核中对p75^NTR和胆酸转移酶 (ChAT) 阳性神经元的免疫组合化学分析.
对p75^NTR,proNGF和ChAT蛋白水平的量化.
使用AT8和Thioflavin-S染色对病理的评估.

主要成果:

与DSD和AMC相比,DSD+病例显示p75^NTR阳性神经元显著减少.
在DSD+中,CHAT阳性细胞的数量明显低于DSD和AMC.
与AMC相比,在DSD+中观察到高的p75^NTR和proNGF水平,以及降低的ChAT水平.
在DSD+中发现了增加的AT8 tau和Thioflavin-S阳性神经纤维状结.

结论:

在患有DS的个体中,p75^NTR/proNGF通路似乎更参与痴呆症.
需要进一步的研究来确定有助于非痴呆症患者 (DSD-) 认知性的因素.

关键词:

细胞生物学细胞生物学神经科学是一个神经科学.

更多相关视频

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices

Published on: April 11, 2018

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...